GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DH · Mar 31, 2025

Definitive Healthcare Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0000950170-25-067044General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

289.12% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

13.02% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

44.04% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-6.76% · CORE · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

73.93% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-312.19% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

15.71% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

12.37% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building

Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20250/8 normalizedLevel 3 Dec 31, 20250/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20267/8 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Increased

Previous: 96.77%
Current: 289.12%
Delta: 192.35%

Capex Intensity Increased

Previous: 4.89%
Current: 13.02%
Delta: 8.12%

Cash Generation Increased

Previous: 23.08%
Current: 44.04%
Delta: 20.96%

Margin Decreased

Previous: 78.30%
Current: 73.93%
Delta: -4.37%

Profitability Decreased

Previous: -281.85%
Current: -312.19%
Delta: -30.34%

R And D Intensity Increased

Previous: 14.48%
Current: 15.71%
Delta: 1.23%

Sbc Intensity Decreased

Previous: 15.10%
Current: 12.37%
Delta: -2.74%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · DH Fundamental State →Transitioned To · DH Fundamental State →Transitioned To · DH BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · DH CAPEX_INTENSITY_INCREASED →Transitioned To · DH CASH_GENERATION_INCREASED →Transitioned To · DH MARGIN_DECREASED →Transitioned To · DH PROFITABILITY_DECREASED →Transitioned To · DH R_AND_D_INTENSITY_INCREASED →Transitioned To · DH SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.